CONMED CORPORATION Amortization of Intangible Assets
CONMED CORPORATION (CNMD) reported Amortization of Intangible Assets of $8.70 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-07-29
- CONMED CORPORATION amortization of intangible assets for the quarter ending 2026-06-30 was $8.70M, a 0.00% change year-over-year.
- CONMED CORPORATION amortization of intangible assets for the quarter ending 2025-12-31 was $9.10M, a 4.60% increase year-over-year.
- CONMED CORPORATION amortization of intangible assets for the quarter ending 2025-09-30 was $8.70M, a 1.14% decline year-over-year.
- CONMED CORPORATION amortization of intangible assets for the quarter ending 2025-06-30 was $8.70M, a 1.16% increase year-over-year.
- CONMED CORPORATION amortization of intangible assets for fiscal 2025 was $35.20M, a 1.44% increase from fiscal 2024.
- CONMED CORPORATION amortization of intangible assets for fiscal 2024 was $34.70M, a 1.42% decline from fiscal 2023.
- CONMED CORPORATION amortization of intangible assets for fiscal 2023 was $35.20M, a 4.45% increase from fiscal 2022.
- CONMED CORPORATION amortization of intangible assets for fiscal 2022 was $33.70M, a 1.20% increase from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 6 month as first filed | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 9 month as first filed | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $8.70M 10-Q · filed 2026-07-29 | $17.50M 10-Q · filed 2026-07-29 | ||||||
| 2025-12-31 | $9.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $17.80M derived: sum of 2 quarters · filed 2026-02-17 | $26.50M derived: sum of 3 quarters · filed 2026-07-29 | $35.20M 10-K · filed 2026-02-17 | ||||
| 2025-09-30 | $8.70M 10-Q · filed 2025-11-06 | $17.40M derived: sum of 2 quarters · filed 2026-07-29 | $26.10M 10-Q · filed 2025-11-06 | $34.80M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-06-30 | $8.70M 10-Q · filed 2026-07-29 | $17.30M 10-Q · filed 2026-07-29 | $26.10M derived: sum of 3 quarters · filed 2026-07-29 | $34.90M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-03-31 | $8.70M 10-Q · filed 2025-05-01 | $17.40M derived: sum of 2 quarters · filed 2026-02-17 | $26.20M derived: sum of 3 quarters · filed 2026-02-17 | $34.80M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2024-12-31 | $8.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $17.50M derived: sum of 2 quarters · filed 2026-02-17 | $26.10M derived: sum of 3 quarters · filed 2026-02-17 | $34.70M 10-K · filed 2026-02-17 | ||||
| 2024-09-30 | $8.80M 10-Q · filed 2025-11-06 | $17.40M derived: sum of 2 quarters · filed 2025-11-06 | $26.00M 10-Q · filed 2025-11-06 | $34.90M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2024-06-30 | $8.60M 10-Q · filed 2025-07-31 | $17.20M 10-Q · filed 2025-07-31 | $26.10M derived: sum of 3 quarters · filed 2026-02-17 | $34.80M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2024-03-31 | $8.60M 10-Q · filed 2025-05-01 | $17.50M derived: sum of 2 quarters · filed 2026-02-17 | $26.20M derived: sum of 3 quarters · filed 2026-02-17 | $35.00M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2023-12-31 | $8.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $17.60M derived: sum of 2 quarters · filed 2026-02-17 | $26.40M derived: sum of 3 quarters · filed 2026-02-17 | $35.20M 10-K · filed 2026-02-17 | ||||
| 2023-09-30 | $8.70M 10-Q · filed 2024-10-31 | $17.50M derived: sum of 2 quarters · filed 2024-10-31 | $26.30M 10-Q · filed 2024-10-31 | $35.10M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-06-30 | $8.80M 10-Q · filed 2024-08-01 | $17.60M 10-Q · filed 2024-08-01 | $26.40M derived: sum of 3 quarters · filed 2025-02-18 | $35.10M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-03-31 | $8.80M 10-Q · filed 2024-04-25 | $17.60M derived: sum of 2 quarters · filed 2025-02-18 | $26.30M derived: sum of 3 quarters · filed 2025-02-18 | $34.50M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2022-12-31 | $8.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $17.50M derived: sum of 2 quarters · filed 2025-02-18 | $25.70M derived: sum of 3 quarters · filed 2025-02-18 | $33.70M 10-K · filed 2025-02-18 | ||||
| 2022-09-30 | $8.70M 10-Q · filed 2023-10-26 | $16.90M derived: sum of 2 quarters · filed 2023-10-26 | $24.90M 10-Q · filed 2023-10-26 | $33.30M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-06-30 | $8.20M 10-Q · filed 2023-07-27 | $16.20M 10-Q · filed 2023-07-27 | $24.60M derived: sum of 3 quarters · filed 2024-02-28 | $32.90M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-03-31 | $8.00M 10-Q · filed 2023-04-27 | $16.40M derived: sum of 2 quarters · filed 2024-02-28 | $24.70M derived: sum of 3 quarters · filed 2024-02-28 | $32.90M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2021-12-31 | $8.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $16.70M derived: sum of 2 quarters · filed 2024-02-28 | $24.90M derived: sum of 3 quarters · filed 2024-02-28 | $33.30M 10-K · filed 2024-02-28 | ||||
| 2021-09-30 | $8.30M 10-Q · filed 2022-10-27 | $16.50M derived: sum of 2 quarters · filed 2022-10-27 | $24.90M 10-Q · filed 2022-10-27 | $33.40M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-06-30 | $8.20M 10-Q · filed 2022-07-28 | $16.60M 10-Q · filed 2022-07-28 | $25.10M derived: sum of 3 quarters · filed 2023-02-21 | $33.70M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-03-31 | $8.30M 10-Q · filed 2022-05-05 | $16.90M derived: sum of 2 quarters · filed 2023-02-21 | $25.50M derived: sum of 3 quarters · filed 2023-02-21 | $34.00M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2020-12-31 | $8.60M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $17.20M derived: sum of 2 quarters · filed 2023-02-21 | $25.70M derived: sum of 3 quarters · filed 2023-02-21 | $34.20M 10-K · filed 2023-02-21 | ||||
| 2020-09-30 | $8.60M 10-Q · filed 2021-10-28 | $17.10M derived: sum of 2 quarters · filed 2021-10-28 | $25.60M 10-Q · filed 2021-10-28 | $33.80M derived: sum of 4 quarters · filed 2022-02-22 | ||||
| 2020-06-30 | $8.50M 10-Q · filed 2021-07-29 | $17.00M 10-Q · filed 2021-07-29 | $25.20M derived: sum of 3 quarters · filed 2022-02-22 | $33.60M derived: sum of 4 quarters · filed 2022-02-22 | ||||
| 2020-03-31 | $8.50M 10-Q · filed 2021-04-29 | $16.70M derived: sum of 2 quarters · filed 2022-02-22 | $25.10M derived: sum of 3 quarters · filed 2022-02-22 | $33.40M derived: sum of 4 quarters · filed 2022-02-22 | ||||
| 2019-12-31 | $8.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $16.60M derived: sum of 2 quarters · filed 2022-02-22 | $24.90M derived: sum of 3 quarters · filed 2022-02-22 | $32.30M 10-K · filed 2022-02-22 | ||||
| 2019-09-30 | $8.40M 10-Q · filed 2020-10-29 | $16.70M derived: sum of 2 quarters · filed 2020-10-29 | $24.10M 10-Q · filed 2020-10-29 | $30.10M derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2019-06-30 | $8.30M 10-Q · filed 2020-07-30 | $15.70M 10-Q · filed 2020-07-30 | $21.70M derived: sum of 3 quarters · filed 2021-02-22 | $27.70M derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2019-03-31 | $7.40M 10-Q · filed 2020-04-30 | $13.40M derived: sum of 2 quarters · filed 2021-02-22 | $19.40M derived: sum of 3 quarters · filed 2021-02-22 | $25.10M derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2018-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $12.00M derived: sum of 2 quarters · filed 2021-02-22 | $17.70M derived: sum of 3 quarters · filed 2021-02-22 | $23.20M 10-K · filed 2021-02-22 | ||||
| 2018-09-30 | $6.00M 10-Q · filed 2019-10-31 | $11.70M derived: sum of 2 quarters · filed 2019-10-31 | $17.20M 10-Q · filed 2019-10-31 | $22.90M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-06-30 | $5.70M 10-Q · filed 2019-08-01 | $11.20M 10-Q · filed 2019-08-01 | $16.90M derived: sum of 3 quarters · filed 2020-02-24 | $22.20M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-03-31 | $5.50M 10-Q · filed 2019-04-26 | $11.20M derived: sum of 2 quarters · filed 2020-02-24 | $16.50M derived: sum of 3 quarters · filed 2020-02-24 | $21.70M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2017-12-31 | $5.70M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $11.00M derived: sum of 2 quarters · filed 2020-02-24 | $16.20M derived: sum of 3 quarters · filed 2020-02-24 | $21.30M 10-K · filed 2020-02-24 | ||||
| 2017-09-30 | $5.30M 10-Q · filed 2018-11-02 | $10.50M derived: sum of 2 quarters · filed 2018-11-02 | $15.60M 10-Q · filed 2018-11-02 | $20.70M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2017-06-30 | $5.20M 10-Q · filed 2018-08-02 | $10.30M 10-Q · filed 2018-08-02 | $15.40M derived: sum of 3 quarters · filed 2019-02-25 | $20.40M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2017-03-31 | $5.20M 10-Q · filed 2018-04-26 | $10.20M derived: sum of 2 quarters · filed 2019-02-25 | $15.20M derived: sum of 3 quarters · filed 2019-02-25 | $20.20M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2016-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $10.00M derived: sum of 2 quarters · filed 2019-02-25 | $15.00M derived: sum of 3 quarters · filed 2019-02-25 | $20.00M 10-K · filed 2019-02-25 | ||||
| 2016-09-30 | $5.00M 10-Q · filed 2017-11-02 | $10.00M derived: sum of 2 quarters · filed 2017-11-02 | $15.00M 10-Q · filed 2017-11-02 | $18.10M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-06-30 | $5.00M 10-Q · filed 2017-07-27 | $10.00M 10-Q · filed 2017-07-27 | $13.10M derived: sum of 3 quarters · filed 2018-02-26 | $16.20M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-03-31 | $5.00M 10-Q · filed 2017-04-27 | $8.10M derived: sum of 2 quarters · filed 2018-02-26 | $11.20M derived: sum of 3 quarters · filed 2018-02-26 | $14.30M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2015-12-31 | $3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $6.20M derived: sum of 2 quarters · filed 2018-02-26 | $9.30M derived: sum of 3 quarters · filed 2018-02-26 | $12.60M 10-K · filed 2018-02-26 | ||||
| 2015-09-30 | $3.10M 10-Q · filed 2016-10-28 | $6.20M derived: sum of 2 quarters · filed 2016-10-28 | $9.50M 10-Q · filed 2016-10-28 | $12.60M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-30 | $3.10M 10-Q · filed 2016-07-28 | $6.40M 10-Q · filed 2016-07-28 | $9.50M derived: sum of 3 quarters · filed 2017-02-27 | $12.80M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-31 | $3.20M 10-Q · filed 2016-05-02 | $6.40M derived: sum of 2 quarters · filed 2017-02-27 | $9.70M derived: sum of 3 quarters · filed 2017-02-27 | $13.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-31 | $3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $6.50M derived: sum of 2 quarters · filed 2017-02-27 | $9.80M derived: sum of 3 quarters · filed 2017-02-27 | $13.00M 10-K · filed 2017-02-27 | ||||
| 2014-09-30 | $3.30M 10-Q · filed 2015-10-23 | $3.27M 10-Q · filed 2014-10-24 | $6.60M derived: sum of 2 quarters · filed 2015-10-23 | $9.80M 10-Q · filed 2015-10-23 | $9.76M 10-Q · filed 2014-10-24 | $14.52M derived: sum of 4 quarters · filed 2016-02-23 | ||
| 2014-06-30 | $3.30M 10-Q · filed 2015-07-27 | $3.28M 10-Q · filed 2014-07-25 | $6.50M 10-Q · filed 2015-07-27 | $6.49M 10-Q · filed 2014-07-25 | $11.22M derived: sum of 3 quarters · filed 2016-02-23 | $14.57M derived: sum of 4 quarters · filed 2016-02-23 | ||
| 2014-03-31 | $3.30M 10-Q · filed 2015-04-24 | $3.32M 10-Q · filed 2014-04-25 | $7.92M derived: sum of 2 quarters · filed 2016-02-23 | $11.27M derived: sum of 3 quarters · filed 2016-02-23 | $14.79M derived: sum of 4 quarters · filed 2016-02-23 | |||
| 2013-12-31 | $4.62M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $7.97M derived: sum of 2 quarters · filed 2016-02-23 | $11.49M derived: sum of 3 quarters · filed 2016-02-23 | $13.70M 10-K · filed 2016-02-23 | $13.72M 10-K · filed 2014-02-24 | |||
| 2013-09-30 | $3.35M 10-Q · filed 2014-10-24 | $6.87M derived: sum of 2 quarters · filed 2014-10-24 | $9.08M 10-Q · filed 2014-10-24 | $13.87M derived: sum of 4 quarters · filed 2015-02-23 | ||||
| 2013-06-30 | $3.52M 10-Q · filed 2014-07-25 | $2.02M 10-Q · filed 2013-07-29 | $7.01M 10-Q · filed 2014-07-25 | $4.01M 10-Q · filed 2013-07-29 | $10.52M derived: sum of 3 quarters · filed 2015-02-23 | $13.95M derived: sum of 4 quarters · filed 2015-02-23 | ||
| 2013-03-31 | $3.49M 10-Q · filed 2014-04-25 | $1.99M 10-Q · filed 2013-04-29 | $7.00M derived: sum of 2 quarters · filed 2015-02-23 | $10.43M derived: sum of 3 quarters · filed 2015-02-23 | $12.36M derived: sum of 4 quarters · filed 2015-02-23 | |||
| 2012-12-31 | $3.51M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23 | $6.94M derived: sum of 2 quarters · filed 2015-02-23 | $8.87M derived: sum of 3 quarters · filed 2015-02-23 | $13.80M 10-K · filed 2015-02-23 | $7.81M 10-K · filed 2013-02-25 | |||
| 2012-09-30 | $3.43M 10-Q · filed 2013-10-28 | $1.93M 10-Q · filed 2012-10-29 | $5.36M derived: sum of 2 quarters · filed 2013-10-28 | $10.29M 10-Q · filed 2013-10-28 | $5.79M 10-Q · filed 2012-10-29 | |||
| 2012-06-30 | $1.93M 10-Q · filed 2013-07-29 | $3.86M 10-Q · filed 2013-07-29 | ||||||
| 2012-03-31 | $1.93M 10-Q · filed 2013-04-29 | |||||||
| 2011-09-30 | $1.60M 10-Q · filed 2012-10-29 | $3.23M derived: sum of 2 quarters · filed 2012-10-29 | $4.85M 10-Q · filed 2012-10-29 | |||||
| 2011-06-30 | $1.63M 10-Q · filed 2012-07-30 | $3.25M 10-Q · filed 2012-07-30 | ||||||
| 2011-03-31 | $1.62M 10-Q · filed 2012-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |